Cargando…

Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of life of patients and the course of chemotherapeutic treatment. Nevertheless, despite its prevalence, the management of the CIPN is considered p...

Descripción completa

Detalles Bibliográficos
Autores principales: Szklener, Katarzyna, Szklener, Sebastian, Michalski, Adam, Żak, Klaudia, Kuryło, Weronika, Rejdak, Konrad, Mańdziuk, Sławomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838672/
https://www.ncbi.nlm.nih.gov/pubmed/35276984
http://dx.doi.org/10.3390/nu14030625
_version_ 1784650183901970432
author Szklener, Katarzyna
Szklener, Sebastian
Michalski, Adam
Żak, Klaudia
Kuryło, Weronika
Rejdak, Konrad
Mańdziuk, Sławomir
author_facet Szklener, Katarzyna
Szklener, Sebastian
Michalski, Adam
Żak, Klaudia
Kuryło, Weronika
Rejdak, Konrad
Mańdziuk, Sławomir
author_sort Szklener, Katarzyna
collection PubMed
description Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of life of patients and the course of chemotherapeutic treatment. Nevertheless, despite its prevalence, the management of the CIPN is considered particularly challenging, with this condition often being perceived as very difficult or even impossible to prevent with currently available agents. Therefore, it is imperative to find better options for patients diagnosed with this condition. While the search for the new agents must continue, another opportunity should be taken into consideration—repurposing of the already known medications. As proposed, acetyl-L-carnitine, vitamins (group B and E), extracts of medical plants, including goshajinkigan, curcumin and others, unsaturated fatty acids, as well as the diet composed of so-called “sirtuin-activating foods”, could change the typical way of treatment of CIPN, improve the quality of life of patients and maintain the continuity of chemotherapy. This review summarizes currently available data regarding mentioned above agents and evaluates the rationale behind future research focused on their efficacy in CIPN.
format Online
Article
Text
id pubmed-8838672
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88386722022-02-13 Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? Szklener, Katarzyna Szklener, Sebastian Michalski, Adam Żak, Klaudia Kuryło, Weronika Rejdak, Konrad Mańdziuk, Sławomir Nutrients Review Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of life of patients and the course of chemotherapeutic treatment. Nevertheless, despite its prevalence, the management of the CIPN is considered particularly challenging, with this condition often being perceived as very difficult or even impossible to prevent with currently available agents. Therefore, it is imperative to find better options for patients diagnosed with this condition. While the search for the new agents must continue, another opportunity should be taken into consideration—repurposing of the already known medications. As proposed, acetyl-L-carnitine, vitamins (group B and E), extracts of medical plants, including goshajinkigan, curcumin and others, unsaturated fatty acids, as well as the diet composed of so-called “sirtuin-activating foods”, could change the typical way of treatment of CIPN, improve the quality of life of patients and maintain the continuity of chemotherapy. This review summarizes currently available data regarding mentioned above agents and evaluates the rationale behind future research focused on their efficacy in CIPN. MDPI 2022-01-31 /pmc/articles/PMC8838672/ /pubmed/35276984 http://dx.doi.org/10.3390/nu14030625 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szklener, Katarzyna
Szklener, Sebastian
Michalski, Adam
Żak, Klaudia
Kuryło, Weronika
Rejdak, Konrad
Mańdziuk, Sławomir
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
title Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
title_full Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
title_fullStr Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
title_full_unstemmed Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
title_short Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
title_sort dietary supplements in chemotherapy-induced peripheral neuropathy: a new hope?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838672/
https://www.ncbi.nlm.nih.gov/pubmed/35276984
http://dx.doi.org/10.3390/nu14030625
work_keys_str_mv AT szklenerkatarzyna dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope
AT szklenersebastian dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope
AT michalskiadam dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope
AT zakklaudia dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope
AT kuryłoweronika dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope
AT rejdakkonrad dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope
AT mandziuksławomir dietarysupplementsinchemotherapyinducedperipheralneuropathyanewhope